The urokinase receptor and cell migration

Seminars in Thrombosis and Hemostasis

Volumn 22, Issue 6, 1996, Pages 513-516

  Blasi, Francesco ^a,b,c  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c HSRaffaele   (Italy)

Author keywords

plasminogen; tyrosine kinase; u PA receptor (u PAR); urokinase plasminogen activator (u PA); 2 macroglobulin receptor (LRP)

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PLASMINOGEN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; UROKINASE; UROKINASE RECEPTOR;

CELL MIGRATION; FIBRINOLYSIS; HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030470950     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-999053     Document Type: Review

References (36)

1. Fazioli F, F Blasi: Urokinase-type plasminogen activator and its receptor: New target for anti-metastatic therapy? Trends Pharm Sci 15:25-29, 1994.
2. Odekon LE, F Blasi, DB Rifkin: A requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J Cell Physiol 158:396-407, 1994.
3. Naldini L, L Tamagnone, E Vigna, M Sachs, G Hartmann, W Birchmeier, Y Daikuhara, H Tsubouchi, F Blasi, PM Comoglio: Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11:4825-4833, 1992.
4. Behrendt N, M Ploug, L Patthy, G Houen, F Blasi, K Danø: The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem 266:7842-7847, 1991.
5. 2-terminal domain of the cellular receptor for human urokinase-type plasminogen activator. A domain structure belonging to a novel super-family of glycolipid-anchored membrane proteins. J Biol Chem 268:17539-17546, 1993.
6. Soravia E, A Grebe, P De Luca, K Helin, TT Suh, JL Degen, F Blasi: A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type plasminogen activator receptor (uPAR) gene. Blood 86:624-635, 1995.
7. Behrendt N, M Ploug, L Patthy, G Houen, F Blasi, K Danø: The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem 266:7842-7847, 1991.
8. Ploug M, V Ellis: Structure - function relationships in the receptor for urokinase-type plasminogen activator. Comparison to the other members of the Ly-6 family and snake venom a-neurotoxins. FEBS Lett 349:163-168, 1994.
9. Riittinen L, P Limongi, MP Crippa, LB Møller, M Conese, L Hernandez-Marrero, F Faziolo, F Blasi: In vivo expression of functional mutant urokinase receptor lacking domain D2 or domain D3. Submitted for publication.
10. Möller LB, J Pöllänen, E Rønne, N Pedersen, F Blasi: N-linked glycosylation of the ligand binding domain of the human urokinase receptor contributes to the affinity to its ligand. J Biol Chem 268:11152-11159, 1993.
11. Picone R, EL Kajtaniak, LS Nielsen, N Behrendt, MR Mastronicola, MV Cubellis, MP Stoppelli, K Danø, F Blasi: Phorbol ester regulates synthesis and affinity of urokinase receptors in monocyte-like U937 cells. J Cell Biol 108:693-702, 1989.
12. Ploug M, E Rønne, N Behrendt, AL Jensen, F Blasi, K Danø: Cellular receptor for urokinase plasminogen activator: Carboxy-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J Biol Chem 266:1926-1933, 1991.
13. Limongi P, M Resnati, L Hernandez-Marrero, O Cremona, F Blasi, F Fazioli: Biosynthesis and apical localization of the urokinase receptor in polarized MDCK epithelial cells. FEBS Lett 369:207-211, 1995.
14. Møller LB, M Ploug, F Blasi: Structural requirements for glycosyl-phosphatidylinositol anchor attachment in the cellular receptor for urokinase plasminogen activator. Eur J Biochem 208:493-500, 1992.
15. Myöhänen HT, RW Stephens, K Hedman, H Tapiovaara, E Rønne, G Høyer-Hansen, K Danø, A Vaheri: Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. J Histochem Cytochem 41:1291-1301, 1993.
16. Resnati M, M Guttinger, S Valcamonica, N Sidenius, F Blasi, F Fazioli: Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J 15: 1996, in press.
17. Rabbani AA, J Desjardins, AW Bell, D Benville, A Mazar, J Henkin, D Goltzman: An aminoterminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoclast-like cells. Biochem Biophys Res Commun 173:1058-1064, 1990.
18. Pierce JH, E Di Marco, GW Cox, D Lombardi, M Ruggiero, L Varesio, LM Wang, GG Choudhouyry, AY Sakaguchi, PP DiFiore, S Aaronson: Macrophage colony stimulating factor (CSF-1) induces proliferation, chemotaxis and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA. Proc Natl Acad Sci USA 87:5613-5617, 1990.
19. Cubellis, MV, T-C Wun, F Blasi: Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J 9:1079-1085, 1990.
20. 2-macroglobulin receptor. J Biol Chem 269:17886-17892, 1994.
21. Cavallaro U, A del Vecchio, DS Lappi, MR Soria: A conjugate between human urokinase and saporin, a type-1 ribosome-inactivating protein, is selectively cytotoxic to urokinase receptor-expressing cells. J Biol Chem 268:23186-23190, 1993.
22. Olson D, J Pöllänen, G Høyer-Hansen, E Roønne, K Sakaguchi, T-C Wun, E Appella, K Danø, F Blasi: Internalization of the urokinase:plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J Biol Chem 267:9129-9133, 1992.
23. Nykjær A, CM Petersen, B Møller, PH Jensen, SK Mœstrup, TL Holtet, M Etzerdot, HC Thøghersen, M Munch, PA Andreasen, J Gliemann: Purified α2 macroglobulin receptor/LDL receptor related protein binds urokinase-plasminogen activator inhibitor type-1 complex. Evidence that α2 macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J Biol Chem 267:14543-14546, 1992.
24. Conese M, A Nykjær, El Christensen, CM Petersen, O Cremona, R Pardi, PA Andreasen, J Gliemann, F Blasi: Alpha-2 macroglobulin receptor-dependent internalization of the urokinase receptor. J Cell Biol 131:1609-1622, 1995.
25. Blasi F: Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness. BioEssays 15:105-111, 1993.
26. Wei Y, D Waltz, N Rao, RJ Drummond, S Rosenberg, HA Chapman: Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem 269:32380-32388, 1994.
27. Waltz DA, LZ Sailor, HA Chapman: Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J Clin Invest 91:1541-1552, 1993.
28. Conese M, U Cavallaro, N Sidenius, D Olson, MR Soria, F Blasi: Down regulation of the α2-macroglobulin/LDL receptor related protein during PMA induced differentiation of human U937 cells. FEBS Lett 358:73-78, 1995.
29. Danø K, N Behrendt, N Brunner, V Ellis, M Ploug, C Pyke: The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 8:189-203, 1994.
30. Quax P, E Frisdal, N Pedersen, S Bonavaud, P Thibert, I Martelly, JH Verheijen, F Blasi, G Barlovatz-Meimon: Modulation of activities of the components of the plasminogen activation system during differentiation of human myogenic satellite cells in vitro. Dev Biol 151:166-175, 1992.
31. Cajot J-F, J Bamat, GE Bergonzeli, EKO Kruithof, RL Medcalf, J Testuz, B Sordat: Plasminogen activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells. Proc Natl Acad Sci USA 87:6939-6943, 1990.
32. Ossowski L, E Reich: Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611-619, 1983.
33. Cajot J-F, WD Schleuning, RL Medcalf, J Bamat, J Testuz, L Liebermann, B Sordat: Mouse L cells expressing human prourokinase-type plasminogen activator: Effects on extracellular matrix degradation and invasion. J Cell Biol 109:915-925, 1989.
34. Hearing VJ, LW Law, A Corti, E Appella, F Blasi: Modulation of metastatic potential by cell surface urokinase of murine cells. Cancer Res 48:1270-1278, 1988.
35. Crowley CW, RL Cohen, BK Lucas, G Liu, MA Shuman, AD Levinson: Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90:5021-5025, 1993.
36. Heiss MM, H Allgayer, KU Gruetzner, I Funke, R Babic, K-W Jauch, FW Schildberg: Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: A reference to early systemic disease in solid cancer. Nature (Medicine) 1:1035-1039, 1995.